{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:06:15Z","timestamp":1790784375909,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011634","name":"TAU | Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100011634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nuclear translocation of transmembrane proteins was reported in high-grade serous ovarian cancer (HGSOC), a highly aggressive gynecological malignancy. Although the membrane receptor \u03b1v\u03b23 integrin is amply expressed in HGSOC and involved in disease progression, its nuclear localization was never demonstrated. Nuclear \u03b1v\u03b23 was explored in HGSOC cells (OVCAR3, KURAMOCHI, and JHOS4), nuclear localization signal (NLS) modified \u03b23 OVCAR3, Chinese hamster ovaries (CHO-K1) and human embryonic kidney (HEK293) before\/after transfections with \u03b23\/\u03b21 integrins. We used the ImageStream technology, Western blots (WB), co immunoprecipitations (Co-IP), confocal immunofluorescence (IF) microscopy, flow cytometry for cell counts and cell cycle, wound healing assays and proteomics analyses. Fresh\/archived tumor tissues were collected from nine HGSOC patients and normal ovarian and fallopian tube (FT) tissues from eight nononcological patients and assessed for nuclear \u03b1v\u03b23 by WB, confocal IF microscopy and immunohistochemistry (IHC). We identified nuclear \u03b1v\u03b23 in HGSOC cells and tissues, but not in normal ovaries and FTs. The nuclear integrin was Tyr 759 phosphorylated and functionally active. Nuclear \u03b1v\u03b23 enriched OVCAR3 cells demonstrated induced proliferation and oncogenic signaling, intact colony formation ability and inhibited migration. Proteomics analyses revealed a network of nuclear \u03b1v\u03b23-bound proteins, many of which with key cancer-relevant activities. Identification of atypical nuclear localization of the \u03b1v\u03b23 integrin in HGSOC challenges the prevalent conception that the setting in which this receptor exerts its pleiotropic actions is exclusively at the cell membrane. This discovery proposes \u03b1v\u03b23 moonlighting functions and may improve our understanding of the molecular basis of ovarian cancer pathogenesis.<\/jats:p>","DOI":"10.1038\/s41389-020-00254-2","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T01:26:46Z","timestamp":1595986006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The identification of nuclear \u03b1v\u03b23 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-128X","authenticated-orcid":false,"given":"Chen","family":"Seraya-Bareket","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Shinderman-Maman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Teper-Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Stamler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissim","family":"Arbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yfat","family":"Kadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Kidron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-3182","authenticated-orcid":false,"given":"Osnat","family":"Ashur-Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson, G. C., Kohn, E. C., Kitchener, H. C. & Ledermann, J. A. Ovarian cancer. Lancet 384, 1376\u20131388 (2014).","journal-title":"Lancet"},{"key":"254_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","volume":"76","author":"R Perets","year":"2016","unstructured":"Perets, R. & Drapkin, R. It\u2019s totally tubular\u2026.riding the new wave of ovarian cancer research. Cancer Res. 76, 10\u201317 (2016).","journal-title":"Cancer Res."},{"key":"254_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm905","volume":"3","author":"A Wells","year":"2002","unstructured":"Wells, A. & Marti, U. Signalling shortcuts: cell-surface receptors in the nucleus? Nat. Rev. Mol. Cell Biol. 3, 697\u2013702 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"254_CR4","first-page":"7","volume":"5","author":"S Maisel","year":"2019","unstructured":"Maisel, S. & Schroeder, J. Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization. J. Cancer Metastasis Treat. 5, 7 (2019).","journal-title":"J. Cancer Metastasis Treat."},{"key":"254_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mc.20504","volume":"48","author":"W Xia","year":"2009","unstructured":"Xia, W. et al. Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer. Mol. Carcinog. 48, 610\u2013617 (2009).","journal-title":"Mol. Carcinog."},{"key":"254_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2559.2011.03761.x","volume":"58","author":"Y Ohishi","year":"2011","unstructured":"Ohishi, Y. et al. Nuclear localization of E\u2010cadherin but not beta\u2010catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. Histopathology 58, 423\u2013432 (2011).","journal-title":"Histopathology"},{"key":"254_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(97)90033-2","volume":"28","author":"H Liapis","year":"1997","unstructured":"Liapis, H., Adler, L. M., Wick, M. R. & Rader, J. S. Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum. Pathol. 28, 443\u2013449 (1997).","journal-title":"Hum. Pathol."},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.onc.1206347","volume":"22","author":"S Cruet-Hennequart","year":"2003","unstructured":"Cruet-Hennequart, S. et al. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22, 1688\u20131702 (2003).","journal-title":"Oncogene"},{"key":"254_CR10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/BC.2003.120","volume":"384","author":"S Hapke","year":"2003","unstructured":"Hapke, S. et al. Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3\/Vitronectin interaction. Biol. Chem. 384, 1073\u20131083 (2003).","journal-title":"Biol. Chem."},{"key":"254_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.1995.1214","volume":"58","author":"SA Cannistra","year":"1995","unstructured":"Cannistra, S. A., Ottensmeier, C., Niloff, J., Orta, B. & DiCarlo, J. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol. Oncol. 58, 216\u2013225 (1995).","journal-title":"Gynecol. Oncol."},{"key":"254_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).","journal-title":"Nat. Commun."},{"key":"254_CR13","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1158\/0008-5472.CAN-13-0602","volume":"73","author":"LM Knowles","year":"2013","unstructured":"Knowles, L. M. et al. Integrin \u03b1v\u03b23 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis. Cancer Res. 73, 6175\u20136184 (2013).","journal-title":"Cancer Res."},{"key":"254_CR14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.1941","volume":"15","author":"AR Reynolds","year":"2009","unstructured":"Reynolds, A. R. et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 15, 392 (2009).","journal-title":"Nat. Med."},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41556-018-0220-2","volume":"20","author":"JG Lock","year":"2018","unstructured":"Lock, J. G. et al. Reticular adhesions are a distinct class of cell-matrix adhesions that mediate attachment during mitosis. Nat. Cell Biol. 20, 1290\u20131302 (2018).","journal-title":"Nat. Cell Biol."},{"key":"254_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","volume":"139","author":"M Novak","year":"2015","unstructured":"Novak, M. et al. Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecol. Oncol. 139, 104\u2013111 (2015).","journal-title":"Gynecol. Oncol."},{"key":"254_CR17","doi-asserted-by":"crossref","first-page":"40943","DOI":"10.1074\/jbc.M111.231951","volume":"286","author":"L Deshmukh","year":"2011","unstructured":"Deshmukh, L., Meller, N., Alder, N., Byzova, T. & Vinogradova, O. Tyrosine phosphorylation as a conformational switch a case study of integrin \u03b23 cytoplasmic tail. J. Biol. Chem. 286, 40943\u201340953 (2011).","journal-title":"J. Biol. Chem."},{"key":"254_CR18","doi-asserted-by":"crossref","unstructured":"Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein\u2013protein association networks, made broadly accessible. Nucleic Acids Res. gkw937 (2016).","DOI":"10.1093\/nar\/gkw937"},{"key":"254_CR19","doi-asserted-by":"crossref","unstructured":"Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v. 14.0). Nature protocols. 14, 703\u2013721 (2019).","DOI":"10.1038\/s41596-019-0128-8"},{"key":"254_CR20","unstructured":"Oliveros, J. C. Venny. An interactive tool for comparing lists with Venn\u2019s diagrams. 2007\u20132015 (2007)."},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","volume":"43","author":"T Metsalu","year":"2015","unstructured":"Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 43, W566\u2013W70 (2015).","journal-title":"Nucleic Acids Res."},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ceb.2018.08.004","volume":"56","author":"JD Humphries","year":"2019","unstructured":"Humphries, J. D., Chastney, M. R., Askari, J. A. & Humphries, M. J. Signal transduction via integrin adhesion complexes. Curr. Opin. Cell Biol. 56, 14\u201321 (2019).","journal-title":"Curr. Opin. Cell Biol."},{"key":"254_CR23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm3599","volume":"14","author":"D Bouvard","year":"2013","unstructured":"Bouvard, D., Pouwels, J., De Franceschi, N. & Ivaska, J. Integrin inactivators: balancing cellular functions in vitro and in vivo. Nat. Rev. Mol. Cell Biol. 14, 430 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"254_CR24","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1096\/fj.12-227132","volume":"27","author":"HY Lin","year":"2013","unstructured":"Lin, H. Y. et al. Nuclear monomeric integrin alphav in cancer cells is a coactivator regulated by thyroid hormone. Faseb J. 27, 3209\u20133216 (2013).","journal-title":"Faseb J."},{"key":"254_CR25","doi-asserted-by":"crossref","first-page":"16282","DOI":"10.18632\/oncotarget.7646","volume":"7","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. A small molecule induces integrin \u03b24 nuclear translocation and apoptosis selectively in cancer cells with high expression of integrin \u03b24. Oncotarget 7, 16282 (2016).","journal-title":"Oncotarget"},{"key":"254_CR26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neo.2015.10.003","volume":"17","author":"LK Mullany","year":"2015","unstructured":"Mullany, L. K. et al. Specific TP53 mutants overrepresented in ovarian cancer impact CNV, TP53 activity, responses to nutlin-3a, and cell survival. Neoplasia 17, 789\u2013803 (2015).","journal-title":"Neoplasia"},{"key":"254_CR27","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"Shtutman, M. et al. The cyclin D1 gene is a target of the \u03b2-catenin\/LEF-1 pathway. Proc. Natl Acad. Sci. 96, 5522\u20135527 (1999).","journal-title":"Proc. Natl Acad. Sci."},{"key":"254_CR28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"254_CR29","doi-asserted-by":"crossref","unstructured":"Ghannam-Shahbari, D. et al. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene 37, 2213\u20132224 (2018).","DOI":"10.1038\/s41388-017-0040-z"},{"key":"254_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2016.03.020","volume":"164","author":"A Mahipal","year":"2016","unstructured":"Mahipal, A. & Malafa, M. Importins and exportins as therapeutic targets in cancer. Pharmacol. Ther. 164, 135\u2013143 (2016).","journal-title":"Pharmacol. Ther."},{"key":"254_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91\u2013100 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"254_CR32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.200304105","volume":"162","author":"JD Hood","year":"2003","unstructured":"Hood, J. D., Frausto, R., Kiosses, W. B., Schwartz, M. A. & Cheresh, D. A. Differential \u03b1v integrin\u2013mediated Ras-ERK signaling during two pathways of angiogenesis. J. cell Biol. 162, 933\u2013943 (2003).","journal-title":"J. cell Biol."},{"key":"254_CR33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/cancers9070082","volume":"9","author":"E Madrazo","year":"2017","unstructured":"Madrazo, E., Conde, A. C. & Redondo-Mu\u00f1oz, J. Inside the cell: Integrins as new governors of nuclear alterations? Cancers 9, 82 (2017).","journal-title":"Cancers"},{"key":"254_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.abb.2019.04.009","volume":"668","author":"L Si","year":"2019","unstructured":"Si, L. et al. MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5. Arch. Biochem. Biophys. 668, 9\u201315 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"254_CR35","doi-asserted-by":"crossref","unstructured":"Zhao, G. et al. Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin \u03b21. J. Clin. Investig. 129, 972\u2013987 (2019).","DOI":"10.1172\/JCI122779"},{"key":"254_CR36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17440","volume":"5","author":"A Teckchandani","year":"2016","unstructured":"Teckchandani, A. & Cooper, J. A. The ubiquitin-proteasome system regulates focal adhesions at the leading edge of migrating cells. Elife 5, e17440 (2016).","journal-title":"Elife"},{"key":"254_CR37","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.18632\/oncotarget.3376","volume":"6","author":"M Muthu","year":"2015","unstructured":"Muthu, M., Cheriyan, V. T. & Rishi, A. K. CARP-1\/CCAR1: a biphasic regulator of cancer cell growth and apoptosis. Oncotarget 6, 6499 (2015).","journal-title":"Oncotarget"},{"key":"254_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/bjc.2011.219","volume":"105","author":"R Sabatier","year":"2011","unstructured":"Sabatier, R. et al. A seven-gene prognostic model for platinum-treated ovarian carcinomas. Br. J. Cancer 105, 304\u2013311 (2011).","journal-title":"Br. J. Cancer"},{"key":"254_CR39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.molcel.2008.08.001","volume":"31","author":"JH Kim","year":"2008","unstructured":"Kim, J. H. et al. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell 31, 510\u2013519 (2008).","journal-title":"Mol. Cell"},{"key":"254_CR40","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.3390\/ijms19103282","volume":"19","author":"E Dietel","year":"2018","unstructured":"Dietel, E., Brobeil, A., Gattenl\u00f6hner, S. & Wimmer, M. The importance of the right framework: mitogen-activated protein kinase pathway and the scaffolding protein PTPIP51. Int. J. Mol. Sci. 19, 3282 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"254_CR41","first-page":"4099","volume":"126","author":"N Elad","year":"2013","unstructured":"Elad, N. et al. The role of integrin-linked kinase in the molecular architecture of focal adhesions. J. Cell Sci. 126, 4099\u20134107 (2013).","journal-title":"J. Cell Sci."},{"key":"254_CR42","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1073\/pnas.0701999104","volume":"104","author":"F Acconcia","year":"2007","unstructured":"Acconcia, F., Barnes, C. J., Singh, R. R., Talukder, A. H. & Kumar, R. Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase. Proc. Natl Acad. Sci. 104, 6782\u20136787 (2007).","journal-title":"Proc. Natl Acad. Sci."},{"key":"254_CR43","first-page":"R341","volume":"20","author":"RM Savoy","year":"2013","unstructured":"Savoy, R. M. & Ghosh, P. M. The dual role of filamin A in cancer: can\u2019t live with (too much of) it, can\u2019t live without it. Endocrine 20, R341\u2013R56 (2013).","journal-title":"Endocrine"},{"key":"254_CR44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/ijms18050936","volume":"18","author":"A Federico","year":"2017","unstructured":"Federico, A. et al. Pan-cancer mutational and transcriptional analysis of the integrator complex. Int. J. Mol. Sci. 18, 936 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"254_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-1236-z","volume":"10","author":"JA Ross","year":"2019","unstructured":"Ross, J. A. et al. Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis. Cell Death Dis. 10, 1\u201315 (2019).","journal-title":"Cell Death Dis."},{"key":"254_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sigtrans.2017.2","volume":"2","author":"M Linxweiler","year":"2017","unstructured":"Linxweiler, M., Schick, B. & Zimmermann, R. Let\u2019s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine. Signal Transduct. Target. Ther. 2, 1\u201310 (2017).","journal-title":"Signal Transduct. Target. Ther."},{"key":"254_CR47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cbpa.2016.06.009","volume":"34","author":"B Di Ventura","year":"2016","unstructured":"Di Ventura, B. & Kuhlman, B. Go in! Go out! Inducible control of nuclear localization. Curr. Opin. Chem. Biol. 34, 62\u201371 (2016).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"254_CR48","doi-asserted-by":"crossref","unstructured":"Shinderman-Maman, E. et al. The thyroid hormone-alphavbeta3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation. Oncogene 35, 1977\u20131987 (2016).","DOI":"10.1038\/onc.2015.262"},{"key":"254_CR49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1541-7786.MCR-11-0187","volume":"9","author":"K Cohen","year":"2011","unstructured":"Cohen, K., Ellis, M., Khoury, S., Davis, P. J., Hercbergs, A. & Ashur-Fabian, O. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via alphavbeta3 integrin. Mol Cancer Res. 9, 1385\u20131394 (2011).","journal-title":"Mol Cancer Res."},{"key":"254_CR50","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1073\/pnas.0607524104","volume":"104","author":"KA Kov\u00e1cs","year":"2007","unstructured":"Kov\u00e1cs, K. A. et al. TORC1 is a calcium-and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc. Natl Acad. Sci. 104, 4700\u20134705 (2007).","journal-title":"Proc. Natl Acad. Sci."},{"key":"254_CR51","first-page":"D331","volume":"45","author":"GO Consortium","year":"2016","unstructured":"Consortium, G. O. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 45, D331\u2013D8 (2016).","journal-title":"Nucleic Acids Res."},{"key":"254_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-488","volume":"7","author":"S Brohee","year":"2006","unstructured":"Brohee, S. & Van Helden, J. Evaluation of clustering algorithms for protein\u2013protein interaction networks. BMC Bioinform. 7, 488 (2006).","journal-title":"BMC Bioinform."}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-020-00254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-020-00254-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-020-00254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:11:42Z","timestamp":1670231502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-020-00254-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1038\/s41389-020-00254-2","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"69"}}